May 7, 2026 07:18AM
May 7, 2026 07:00AM
Mar 18, 2026 07:46AM
Mar 17, 2026 07:17AM
Mar 17, 2026 07:00AM
Nov 6, 2025 07:06AM
Nov 6, 2025 07:00AM Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
Sep 15, 2025 07:01AM
Sep 15, 2025 07:00AM
Aug 7, 2025 07:04AM
Aug 7, 2025 07:00AM
May 8, 2025 07:05AM
May 8, 2025 07:00AM
Mar 20, 2025 07:04AM Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue
Mar 20, 2025 07:00AM
Mar 11, 2025 07:00AM
Nov 7, 2024 07:23AM
Nov 7, 2024 07:05AM
Nov 7, 2024 07:00AM
Oct 28, 2024 07:01AM
Oct 28, 2024 07:00AM Monte Rosa Therapeutics Announces Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
Aug 8, 2024 07:13AM
Aug 8, 2024 07:00AM
May 21, 2024 07:00AM
May 9, 2024 07:14AM
May 9, 2024 07:00AM
Mar 14, 2024 07:00AM
Nov 9, 2023 07:03AM Monte Rosa Therapeutics, Inc. (GLUE) Tops Q3 EPS by 2c
Nov 9, 2023 07:00AM
Aug 10, 2023 07:17AM
Aug 10, 2023 07:15AM
May 11, 2023 07:30AM
Mar 16, 2023 07:30AM
Nov 10, 2022 07:30AM
Aug 11, 2022 07:30AM Monte Rosa Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates
May 11, 2022 07:30AM
Mar 29, 2022 07:30AM
Nov 10, 2021 07:30AM
Aug 12, 2021 07:30AM

1,197,313 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All